Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment.
Phunsup WongsurakiatSiwadol SunhapanitNisa MuangmanPublished in: Influenza and other respiratory viruses (2022)
RSV-ARI may result in significant mortality and health care utilization. Treatment with oral ribavirin may improve survival in these patients.
Keyphrases
- end stage renal disease
- respiratory syncytial virus
- healthcare
- ejection fraction
- newly diagnosed
- prognostic factors
- cardiovascular disease
- metabolic syndrome
- intensive care unit
- cardiovascular events
- patient reported outcomes
- insulin resistance
- extracorporeal membrane oxygenation
- health insurance
- glycemic control